Cloud-based video editing technology developer Blackbird (LON: BIRD) despite today’s confirmation that elevate.io is available on the Google Perks platform in the UK. This enables Chromebook users to access elevate.io at a discounted rate – a 50% discount for a six-month period or a 25% discount on an annual subscription for one of the three tiers on offer. There are nearly one million Chromebooks sold annually in the UK and tens of millions of Chromebook users around the world. Existing and new users can take advantage of this browser-based offer. There are currently just over 1,000 elevate.io subscribers. If the pilot is successful, it could be rolled out in other countries. The share price has jumped 94.4% to 3.5p.
Falkland Islands – focused oil and gas explorer Borders & Southern Petroleum (LON: BOR) is raising £2m at 11.5p/share from a high net worth investor in the Middle East. This should fund the company until mid-2028, while it has farm out discussions about its assets. The fundraising share price was at a premium to the market price, which is still lower even though it has risen 34.9% to 10.95p.
Cybersecurity company Corero Network Security (LON: CNS) revealed third quarter order intake rose 50% to $11.1m. Year to date orders are 28% higher at $25.4m. Corero is thought to be gaining market share in DDoS protection. Full year revenues are forecast to improve from $25.5m to $31.9m, and the order book underpins this and a move into profit. Canaccord Genuity has a share price target of 21p. The current share price is 32.6% to 15.25p.
Roundhouse AI (LON: RHAI) has made the move from Aquis to AIM, raising £1.59m at 5p/share. The last Aquis share price was 5.75p. The cash will fund progress in developing and enhancing the profile of AI agent deployment infrastructure. This shows who is being paid and the related costs. The dashboard is already live and free to use. The share price is 28.3% higher than the last Aquis price at 7.25p.
FALLERS
A major client loss at productivity optimisation software provider ActiveOps (LON: AOM) has offset growth elsewhere. Interim revenues are 21% ahead at £25.3m, which is organic growth of 5%. The growth is in SaaS revenues. The loss of the customer next March will not affect the current financial year, but it will reduce the 2027-28 revenues by £3.8m. Canaccord Genuity has cut its 2027-28 pre-tax profit forecast from £5.2m to £3.5m. Net cash would be £29.4m at that point. Octopus subsequently increased its stake from 14.2% to 15.98%. The share price slumped 54.4% to 102.5p.
Jarvis Securities (LON: JIM) says it will consider credible reverse takeover opportunities, but winding up the company is still the current intention. Jarvis Investment Management has been placed into Special Administration and S&W Partners has been appointed to the role. This makes Jarvis Securities a cash shell. There was £2.5m in cash at the end of September 2026. The 2025-26 results should be released before the end of the year. The share price halved to 4p, which capitalises the company at £1.8m.
Antibody discovery company Fusion Antibodies (LON: FAB) interim revenues declined from £838,000 to £457,000 with margins reducing. Cash was £135,000 at the end of September 2026, with more than £100,000 of grant funding expected. Cost reductions have been made and working capital requirements are being reviewed. The share price slipped 35.5% to 6.45p.
Helium One Global (LON: HE1) has raised £3m at 0.29p/share. This will finance the continued development of the 50% owned Galactica-Pegasus Project in Colorado, where the operator is Blue Star Helium, and pay for the annual mining licence fee for the southern Rukwa helium project. The share price declined 32.3% to 0.3075p.